Mycoplasma contamination in cell culture is one of the most common and most easily missed threats to reproducible research, because these wall-less bacteria rarely change how a culture looks. A dependable quality-control strategy therefore has to do more than detect the organism: laboratories need a practical workflow to detect contamination, eliminate it when a culture is worth saving, and confirm that the culture is clean before it returns to experimental use (Drexler & Uphoff, Cytotechnology 2002).
Recommended workflow: screen cultures on a routine schedule, treat contaminated cultures when recovery is justified, and retest after treatment to confirm successful mycoplasma removal.
Use PCR, qPCR, or LAMP-based testing to identify contamination before any visible change appears in the culture.
Apply a validated mycoplasma elimination reagent when a rare, engineered, or high-value cell line is worth preserving.
Retest treated cultures with a sensitive detection method before returning them to critical experiments.
Why Mycoplasma Contamination in Cell Culture Goes Undetected
Unlike bacterial or fungal contamination, mycoplasma contamination in cell culture usually does not cause cloudy media, sharp pH shifts, or rapid cell death. Contaminated cells can look healthy under the microscope while their growth rate, metabolism, gene expression, and immune signaling are quietly altered. RNA-sequencing studies have shown that mycoplasma presence shifts baseline transcription and changes how cells respond to drug treatment (Doyle et al., J Med Microbiol 2021), and infection with Mycoplasma hyorhinis can rewire host pathways such as L-arginine and iNOS regulation (Kagemann et al., Biol Chem 2005).
These hidden effects are not limited to one cell type. Mycoplasma has been shown to alter the differentiation and function of human dendritic cells, and removing the contamination reversed those effects — evidence that many published results from contaminated cultures may need re-evaluation (Chen & Chang, J Biomed Sci 2005). Because mycoplasma can pass through standard 0.22 µm sterile filters and spread through shared reagents, aerosols, or cross-contamination between cultures, testing only when a problem is suspected allows contamination to spread before it is ever noticed.
Who Should Test for Mycoplasma, and When
Any laboratory that maintains mammalian cell lines should build mycoplasma testing into its routine workflow — academic labs, biotech and pharmaceutical groups, contract research organizations, viral-vector production teams, and cell-therapy facilities alike.
Testing is especially important at defined control points: when a new cell line enters the laboratory, after frozen stocks are thawed, before long-term experiments begin, and before high-value applications such as RNA sequencing, proteomics, gene editing, viral-vector production, or therapeutic manufacturing. Regular screening protects individual experiments while reducing the risk that a single contaminated culture spreads to every other line in the facility.
How to Detect Mycoplasma Contamination
Molecular detection methods are the practical first line because they identify contamination before any visible change occurs. PCR-based testing amplifies conserved mycoplasma DNA sequences and is well suited to routine screening. Real-time qPCR adds sensitivity and a closed-tube workflow that reduces post-amplification handling and contamination risk, while LAMP (loop-mediated isothermal amplification) runs at a single temperature and can give a visual colorimetric readout with minimal instrumentation. Independent reviews rank sensitive nucleic-acid methods among the most reliable options for cell-culture screening (Drexler & Uphoff, Cytotechnology 2002).
MycAway™ Mycoplasma qPCR Detection Kit (2G)
A qPCR-based kit for sensitive molecular detection of mycoplasma in cell-culture QC workflows.
MycAway™ Plus-Color One-Step Mycoplasma Detection Kit
A rapid colorimetric option for a simple, low-instrumentation routine screen.
Browse the full range of amplification reagents in the PCR, qPCR & RT-PCR collection.
What to Do If a Culture Tests Positive
When mycoplasma is detected, the safest option is often to discard the culture and replace it with a verified clean stock. That is not always practical: some lines are rare, patient-derived, heavily engineered, or tied to long-term work. In those cases, elimination can be justified. Before treating, isolate the contaminated culture from other cells, and review shared media, supplements, incubators, biosafety cabinets, and handling practices — treating one culture without removing the source of contamination usually leads to reinfection.
How to Eliminate Mycoplasma Contamination
Antibiotic-based elimination is the established route for rescuing valuable cultures. Fluoroquinolones, tetracyclines, macrolides, and pleuromutilins with strong anti-mycoplasma activity are applied alone, in sequence, or in combination to clear the organism while preserving the mammalian cells; well-designed protocols also aim to prevent the emergence of resistant mycoplasma strains (Uphoff & Drexler, Curr Protoc Mol Biol 2014). During treatment, monitor the cells closely and follow the reagent's instructions exactly, since passage timing and cell density both affect recovery.
Important: elimination is not complete the moment treatment ends. Allow the treated culture to recover, then retest with a sensitive detection method before using it for any critical experiment.
How to Confirm Successful Elimination
Confirmation testing is the step most often skipped and most worth keeping. Low levels of residual mycoplasma can survive treatment and expand again if the culture is returned to routine use too soon. Retest with qPCR or LAMP after the culture has recovered, and for high-value experiments consider testing more than once to raise confidence that the contamination is truly gone.
Best Practices for Long-Term Prevention
Routine prevention is far cheaper than an emergency response. Test new cell lines before they enter shared culture areas, verify recovered frozen stocks before use, and screen actively maintained cultures on a fixed schedule. Support that schedule with disciplined aseptic technique, dedicated (not shared) open reagent bottles per cell line, and consistent cleaning of biosafety cabinets and incubators. A workable cadence is: screen every newly received line, check cultures before major experiments, and retest after any contamination event or elimination treatment.
Frequently Asked Questions
How often should I test cell cultures for mycoplasma?
Screen every new or recovered cell line before it joins shared culture space, and test actively maintained cultures on a regular schedule (many labs test every 2–4 weeks) plus before any high-value experiment.
Can I see mycoplasma contamination under a microscope?
No — mycoplasma is usually invisible by standard light microscopy and rarely turns media cloudy, which is exactly why molecular testing by PCR, qPCR, or LAMP is necessary.
Do antibiotics in my media prevent mycoplasma contamination?
Not reliably — mycoplasmas are naturally resistant to many of the antibiotics routinely added to media, so their presence does not guarantee a mycoplasma-free culture (Drexler & Uphoff, Cytotechnology 2002).
Should I treat a contaminated culture or discard it?
Discard and replace with a clean stock whenever possible; reserve antibiotic-based elimination for rare, engineered, or irreplaceable cell lines, and always confirm clearance by retesting afterward.
References
According to PubMed:
- Drexler HG, Uphoff CC. Mycoplasma contamination of cell cultures: incidence, sources, effects, detection, elimination, prevention. Cytotechnology. 2002;39(2):75–90. doi:10.1023/A:1022913015916
- Uphoff CC, Drexler HG. Eradication of mycoplasma contaminations from cell cultures. Curr Protoc Mol Biol. 2014;106:28.5.1–28.5.12. doi:10.1002/0471142727.mb2805s106
- Chen X, Chang LJ. Mycoplasma-mediated alterations of in vitro generation and functions of human dendritic cells. J Biomed Sci. 2005;12(1):31–46. doi:10.1007/s11373-004-8181-9
- Kagemann G, et al. Impact of Mycoplasma hyorhinis infection on L-arginine metabolism. Biol Chem. 2005;386(10):1055–63. doi:10.1515/BC.2005.121
- Doyle C, et al. Mycoplasma affects baseline gene expression and the response to glucocorticoids in vocal fold fibroblasts. J Med Microbiol. 2021;70(5). doi:10.1099/jmm.0.001362
